VX-222 is a novel, potent and selective inhibitor of non-nucleoside polymerase of the hepatitis C virus (HCV) RNA-dependent RNA polymerase, with an IC50 range of 0.94-1.2 µM. VX-222 selectively inhibits the replication of both HCV1a and HCV1b.
产品名称 | VX-222 - Protease - Inhibitors / Activators |
产品货号 | 27053 |
产品价格 | 现货询价,电话:010-67529703 |
产品规格 | 5 mg |
产品品牌 | bpsbioscience |
产品概述 | |
产品详情 |
MW: 445.6 Da
CAS Registry #: 1026785-55-6
Formula: C25H35NO4S
Description: VX-222 is a novel, potent and selective inhibitor of non-nucleoside polymerase of the hepatitis C virus (HCV) RNA-dependent RNA polymerase, with an IC50 range of 0.94-1.2 µM. VX-222 selectively inhibits the replication of both HCV1a and HCV1b. Synonym(s): VCH-222
Purity: ≥98% Solubility: ≥50 mg/ml in DMSO
Format: White crystalline powder
Storage / Stability: Store at or below –20°C. Solid form is stable at least 12 months from date of receipt, when stored as directed. Do not store aqueous solutions for more than one day.
Scientific Category: Protease
Product Type: Inhibitor
Data shown is lot-specific. Contact us for specific information on other lots.
|
产品资料 |